Advertisement



More in Pharmacy

Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street Journal reported Jan. 28. 

While the American Society of Health-System Pharmacists largely supports CMS' proposed policy revisions for Medicare Part D, Medicare Advantage and the program of all-inclusive care for the elderly, or PACE, the ASHP is asking the agency to "change course" on…

Tirzepatide, the active ingredient in Eli Lilly's diabetes drug Mounjaro, may be an effective alternative to painful daily treatment for a rare disorder, according to research published Jan. 29 in The New England Journal of Medicine. 

To alleviate healthcare access strains, Intermountain Health is broadening its on-demand pharmacy and lab services, ABC4 Utah reported Jan. 28. 

The FDA issued a warning letter to ProRx, a compounding facility in Exton, Penn., after an inspection raised serious concerns regarding the safety and compliance of its drug products. The facility, which registered as an outsourcing drug compounder in April…

The FDA has approved Ozempic to reduce the risk of kidney disease worsening, kidney failure and cardiovascular-related death in adults with Type 2 diabetes and chronic kidney disease. 

Advertisement
Advertisement
Advertisement